{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "20371706", "DateCompleted": {"Year": "2010", "Month": "07", "Day": "13"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1124/jpet.110.166678"], "ArticleDate": [{"Year": "2010", "Month": "04", "Day": "06"}], "Journal": {"ISSN": "1521-0103", "JournalIssue": {"Volume": "334", "Issue": "1", "PubDate": {"Year": "2010", "Month": "Jul"}}, "Title": "The Journal of pharmacology and experimental therapeutics", "ISOAbbreviation": "J Pharmacol Exp Ther"}, "ArticleTitle": "Deletion of microsomal prostaglandin E synthase-1 does not alter ozone-induced airway hyper-responsiveness.", "Pagination": {"StartPage": "63", "EndPage": "68", "MedlinePgn": "63-8"}, "Abstract": {"AbstractText": ["Nonsteroidal anti-inflammatory drugs ameliorate pain and fever by inhibiting cyclooxygenase (COX) and suppressing prostanoid formation. Microsomal prostaglandin E synthase-1 (mPGES-1) catalyzes formation of PGE(2) from the COX product PGH(2) and has emerged as a therapeutic target. Inhibition of mPGES-1, however, renders the PGH(2) substrate available for diversion to other PG synthases. To address the possibility that substrate diversion augments formation of PGs that might modulate bronchial tone, we assessed the impact of mPGES-1 deletion in a mouse model of ozone-induced airway hyper-responsiveness. Ozone exposure increased total lung resistance to inhaled methacholine in wild-type mice. Deletion of mPGES-1 had little effect on total lung resistance in either naive or ozone-exposed animals. The carbachol-induced narrowing of luminal diameter in intrapulmonary airways of lung slices from acute ozone-exposed mice was also unaltered by mPGES-1 deletion. Likewise, although concentrations of PGE(2) were reduced in bronchoalveolar lavage fluid, whereas 6-keto-PGF(1alpha), PGD(2), and PGF(2alpha), all were increased, deletion of mPGES-1 failed to influence cell trafficking into the airways of either naive or ozone-exposed animals. Despite biochemical evidence of PGH(2) substrate diversion to potential bronchomodulator PGs, deletion of mPGES-1 had little effect on ozone-induced airway inflammation or airway hyper-responsiveness. Pharmacologically targeting mPGES-1 may not predispose patients at risk to airway dysfunction."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, PA 19104, USA. miaowang@upenn.edu"}], "Identifier": [], "LastName": "Wang", "ForeName": "Miao", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cooper", "ForeName": "Philip R", "Initials": "PR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jiang", "ForeName": "Meiqi", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhao", "ForeName": "Hengjiang", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hui", "ForeName": "Yiqun", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yao", "ForeName": "Yubing", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tate", "ForeName": "Joshua C", "Initials": "JC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Damera", "ForeName": "Gautam", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lawson", "ForeName": "John A", "Initials": "JA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jester", "ForeName": "William F", "Initials": "WF", "Suffix": "Jr"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Haczku", "ForeName": "Angela", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Panettieri", "ForeName": "Reynold A", "Initials": "RA", "Suffix": "Jr"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "FitzGerald", "ForeName": "Garret A", "Initials": "GA"}], "GrantList": [{"GrantID": "P50 HL083799", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL080676", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "P30 ES013508", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "HL080676", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "ES013508", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "HL083799", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Pharmacol Exp Ther", "NlmUniqueID": "0376362", "ISSNLinking": "0022-3565"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Prostaglandins"}, {"RegistryNumber": "0W5ETF9M2K", "NameOfSubstance": "Methacholine Chloride"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "8Y164V895Y", "NameOfSubstance": "Carbachol"}, {"RegistryNumber": "EC 5.3.-", "NameOfSubstance": "Intramolecular Oxidoreductases"}, {"RegistryNumber": "EC 5.3.99.3", "NameOfSubstance": "Prostaglandin-E Synthases"}, {"RegistryNumber": "EC 5.3.99.3", "NameOfSubstance": "Ptges protein, mouse"}, {"RegistryNumber": "K7Q1JQR04M", "NameOfSubstance": "Dinoprostone"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Airway Resistance"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Carbachol"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Differentiation"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Dinoprostone"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Gene Deletion"}, {"QualifierName": ["deficiency", "physiology"], "DescriptorName": "Intramolecular Oxidoreductases"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Methacholine Chloride"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Knockout"}, {"QualifierName": ["enzymology"], "DescriptorName": "Microsomes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle Contraction"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle, Smooth"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Prostaglandin-E Synthases"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Prostaglandins"}, {"QualifierName": ["drug effects", "enzymology", "immunology", "metabolism"], "DescriptorName": "Respiratory System"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Cheng Y, Wang M, Yu Y, Lawson J, Funk CD, Fitzgerald GA. (2006) Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest 116:1391\u20131399", "ArticleIdList": ["PMC1435722", "16614756"]}, {"Citation": "Coffey MJ, Wheeler CS, Gross KB, Eschenbacher WL, Sporn PH, Peters-Golden M. (1996) Increased 5-lipoxygenase metabolism in the lungs of human subjects exposed to ozone. Toxicology 114:187\u2013197", "ArticleIdList": ["8980708"]}, {"Citation": "Cooper PR, Mesaros AC, Zhang J, Christmas P, Stark CM, Douaidy K, Mittelman MA, Soberman RJ, Blair IA, Panettieri RA., Jr (2010) 20-HETE mediates ozone-induced, neutrophil-independent airway hyper-responsiveness in mice. PLoS ONE, in press", "ArticleIdList": ["PMC2857875", "20422032"]}, {"Citation": "Cooper PR, Lamb R, Day ND, Branigan PJ, Kajekar R, San Mateo L, Hornby PJ, Panettieri RA., Jr (2009) TLR3 activation stimulates cytokine secretion without altering agonist-induced human small airway contraction or relaxation. Am J Physiol Lung Cell Mol Physiol 297:L530\u2013L537", "ArticleIdList": ["19542247"]}, {"Citation": "Cooper PR, Panettieri RA., Jr (2008) Steroids completely reverse albuterol-induced \u03b2(2)-adrenergic receptor tolerance in human small airways. J Allergy Clin Immunol 122:734\u2013740", "ArticleIdList": ["18774166"]}, {"Citation": "Engblom D, Saha S, Engstr\u00f6m L, Westman M, Audoly LP, Jakobsson PJ, Blomqvist A. (2003) Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat Neurosci 6:1137\u20131138", "ArticleIdList": ["14566340"]}, {"Citation": "FitzGerald GA. (2007) COX-2 in play at the AHA and the FDA. Trends Pharmacol Sci 28:303\u2013307", "ArticleIdList": ["17573128"]}, {"Citation": "Grosser T, Yu Y, Fitzgerald GA. (2010) Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu Rev Med 61:17\u201333", "ArticleIdList": ["20059330"]}, {"Citation": "Hammad H, Kool M, Soulli\u00e9 T, Narumiya S, Trottein F, Hoogsteden HC, Lambrecht BN. (2007) Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med 204:357\u2013367", "ArticleIdList": ["PMC2118726", "17283205"]}, {"Citation": "Holroyde MC, Norris AA. (1988) The effect of ozone on reactivity of upper and lower airways in guinea pigs. Br J Pharmacol 94:938\u2013946", "ArticleIdList": ["PMC1854056", "3179617"]}, {"Citation": "Honda T, Segi-Nishida E, Miyachi Y, Narumiya S. (2006) Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J Exp Med 203:325\u2013335", "ArticleIdList": ["PMC2118213", "16446378"]}, {"Citation": "Idzko M, Hammad H, van Nimwegen M, Kool M, Vos N, Hoogsteden HC, Lambrecht BN. (2007) Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. J Clin Invest 117:464\u2013472", "ArticleIdList": ["PMC1783814", "17273558"]}, {"Citation": "Jaffar Z, Wan KS, Roberts K. (2002) A key role for prostaglandin I2 in limiting lung mucosal Th2, but not Th1, responses to inhaled allergen. J Immunol 169:5997\u20136004", "ArticleIdList": ["12421986"]}, {"Citation": "Jakobsson PJ, Thor\u00e9n S, Morgenstern R, Samuelsson B. (1999) Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 96:7220\u20137225", "ArticleIdList": ["PMC22058", "10377395"]}, {"Citation": "Kamei D, Yamakawa K, Takegoshi Y, Mikami-Nakanishi M, Nakatani Y, Oh-Ishi S, Yasui H, Azuma Y, Hirasawa N, Ohuchi K, et al. (2004) Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin E synthase-1. J Biol Chem 279:33684\u201333695", "ArticleIdList": ["15140897"]}, {"Citation": "Kierstein S, Krytska K, Sharma S, Amrani Y, Salmon M, Panettieri RA, Jr, Zangrilli J, Haczku A. (2008) Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyper-responsiveness in allergen-sensitized mice. Allergy 63:438\u2013446", "ArticleIdList": ["18315731"]}, {"Citation": "Kierstein S, Poulain FR, Cao Y, Grous M, Mathias R, Kierstein G, Beers MF, Salmon M, Panettieri RA, Jr, Haczku A. (2006) A susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D. Respir Res 7:85.", "ArticleIdList": ["PMC1488844", "16740162"]}, {"Citation": "Math\u00e9 AA, Hedqvist P, Holmgren A, Svanborg N. (1973) Bronchial hyper-reactivity to prostaglandin F2 and histamine in patients with asthma. Br Med J 1:193\u2013196", "ArticleIdList": ["PMC1588140", "4686554"]}, {"Citation": "Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, Kabashima K, Sugimoto Y, Kobayashi T, Ushikubi F, Aze Y, et al. (2000) Prostaglandin D2 as a mediator of allergic asthma. Science 287:2013\u20132017", "ArticleIdList": ["10720327"]}, {"Citation": "Mbalaviele G, Pauley AM, Shaffer AF, Zweifel BS, Mathialagan S, Mnich SJ, Nemirovskiy OV, Carter J, Gierse JK, Wang JL, et al. (2010) Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor. Biochem Pharmacol 79:1445\u20131454", "ArticleIdList": ["20067770"]}, {"Citation": "Murakami M, Kudo I. (2006) Prostaglandin E synthase: a novel drug target for inflammation and cancer. Curr Pharm Des 12:943\u2013954", "ArticleIdList": ["16533161"]}, {"Citation": "Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y, Ichikawa A, Aze Y, Tanaka T, Yoshida N, et al. (1997) Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388:678\u2013682", "ArticleIdList": ["9262402"]}, {"Citation": "Nagao K, Tanaka H, Komai M, Masuda T, Narumiya S, Nagai H. (2003) Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice. Am J Respir Cell Mol Biol 29:314\u2013320", "ArticleIdList": ["12676807"]}, {"Citation": "Narumiya S, Sugimoto Y, Ushikubi F. (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193\u20131226", "ArticleIdList": ["10508233"]}, {"Citation": "Oguma T, Asano K, Ishizaka A. (2008) Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma. Allergol Int 57:307\u2013312", "ArticleIdList": ["18946232"]}, {"Citation": "Pini B, Grosser T, Lawson JA, Price TS, Pack MA, FitzGerald GA. (2005) Prostaglandin E synthases in zebrafish. Arterioscler Thromb Vasc Biol 25:315\u2013320", "ArticleIdList": ["15576635"]}, {"Citation": "Ressmeyer AR, Larsson AK, Vollmer E, Dahl\u00e8n SE, Uhlig S, Martin C. (2006) Characterisation of guinea pig precision-cut lung slices: comparison with human tissues. Eur Respir J 28:603\u2013611", "ArticleIdList": ["16737991"]}, {"Citation": "Samuelsson B, Morgenstern R, Jakobsson PJ. (2007) Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev 59:207\u2013224", "ArticleIdList": ["17878511"]}, {"Citation": "Scholich K, Geisslinger G. (2006) Is mPGES-1 a promising target for pain therapy? Trends Pharmacol Sci 27:399\u2013401", "ArticleIdList": ["16815559"]}, {"Citation": "Seltzer J, Bigby BG, Stulbarg M, Holtzman MJ, Nadel JA, Ueki IF, Leikauf GD, Goetzl EJ, Boushey HA. (1986) O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol 60:1321\u20131326", "ArticleIdList": ["3084448"]}, {"Citation": "Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, Vaghi A, Folco GC, Bianco S, Robuschi M. (1996) Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 153:572\u2013575", "ArticleIdList": ["8564100"]}, {"Citation": "Swedin L, Neimert-Andersson T, Hjoberg J, Jonasson S, van Hage M, Adner M, Ryrfeldt A, Dahl\u00e9n SE. (2009) Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice. Eur Respir J 34:200\u2013208", "ArticleIdList": ["19251789"]}, {"Citation": "Takahashi Y, Tokuoka S, Masuda T, Hirano Y, Nagao M, Tanaka H, Inagaki N, Narumiya S, Nagai H. (2002) Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br J Pharmacol 137:315\u2013322", "ArticleIdList": ["PMC1573495", "12237250"]}, {"Citation": "Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I. (2000) Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 275:32775\u201332782", "ArticleIdList": ["10922363"]}, {"Citation": "Thor\u00e9n S, Weinander R, Saha S, Jegersch\u00f6ld C, Pettersson PL, Samuelsson B, Hebert H, Hamberg M, Morgenstern R, Jakobsson PJ. (2003) Human microsomal prostaglandin E synthase-1: purification, functional characterization, and projection structure determination. J Biol Chem 278:22199\u201322209", "ArticleIdList": ["12672824"]}, {"Citation": "Tilley SL, Hartney JM, Erikson CJ, Jania C, Nguyen M, Stock J, McNeisch J, Valancius C, Panettieri RA, Jr, Penn RB, et al. (2003) Receptors and pathways mediating the effects of prostaglandin E2 on airway tone. Am J Physiol Lung Cell Mol Physiol 284:L599\u2013L606", "ArticleIdList": ["12618422"]}, {"Citation": "Trebino CE, Stock JL, Gibbons CP, Naiman BM, Wachtmann TS, Umland JP, Pandher K, Lapointe JM, Saha S, Roach ML, et al. (2003) Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci USA 100:9044\u20139049", "ArticleIdList": ["PMC166435", "12835414"]}, {"Citation": "Wang M, Lee E, Song W, Ricciotti E, Rader DJ, Lawson JA, Pur\u00e9 E, FitzGerald GA. (2008) Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation 117:1302\u20131309", "ArticleIdList": ["18285567"]}, {"Citation": "Wang M, Zukas AM, Hui Y, Ricciotti E, Pur\u00e9 E, FitzGerald GA. (2006) Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proc Natl Acad Sci USA 103:14507\u201314512", "ArticleIdList": ["PMC1566188", "16973753"]}, {"Citation": "Xu D, Rowland SE, Clark P, Giroux A, C\u00f4t\u00e9 B, Guiral S, Salem M, Ducharme Y, Friesen RW, M\u00e9thot N, et al. (2008) MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation. J Pharmacol Exp Ther 326:754\u2013763", "ArticleIdList": ["18524979"]}]}], "History": [{"Year": "2010", "Month": "4", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "4", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "7", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "7", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20371706", "PMC2912039", "10.1124/jpet.110.166678", "jpet.110.166678"]}}], "PubmedBookArticle": []}